Skip to content

Clinical trials

Diffuse Intrinsic Pontine Glioma trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diffuse Intrinsic Pontine Glioma Country / region: Spain Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20191
20201
20211
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting2
Completed2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company1
Fundació Sant Joan de Déu1
GlaxoSmithKline1
Gustave Roussy, Cancer Campus, Grand Paris1
Hospital Infantil Universitario Niño Jesús, Madrid, Spain1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diffuse Intrinsic Pontine Glioma6
Medulloblastoma3
Rhabdomyosarcoma3
Ependymoma2
Glioblastoma2
Neuroblastoma2
Osteosarcoma2
Rhabdoid Tumor2
Sarcoma, Ewing2
Bone Neoplasms1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.